跳至主要内容
临床试验/IRCT201610209014N123
IRCT201610209014N123已完成2 期

Effect of Repetitive Transcranial Magnetic Stimulation approved by FDA (rTMS-FDA) versus Repetitive Transcranial Magnetic Stimulation with concentration on Mirror Neuron System (rTMS-MNS) on emotion and mood regulation in patients with major depressive disorder: a randomized clinical trial

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • major depressive disorder; age of 18 to 65 years; receiving standard anti-depression drugs.
  • Exclusion criteria: pregnancy; drug abuse during the last month; drug addiction during the last six months; neurologic disease or convulsion; having metal implant; using lorazepam, benzodiazepines, monoamine oxidase enzyme inhibitors or bupropion in the last month.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences

相似试验